Trial intelligence / Profile preview

Effect of Octreotide on Colonic Motility in Pediatric Patients

NCT01917773Phase 4Completed

Sponsor
Indiana University
Start
Aug 2013
Primary completion
Jun 2014
Modality
Peptides
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of octreotide in constipation and colonic motility dysfunction, sponsored by Indiana University. Primary endpoint: Colonic Motility Index. Started Aug 2013; status: completed.

02

Drugs

octreotide
03

Conditions

constipationcolonic motility dysfunction

Beyond the preview

Go deeper on NCT01917773.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01917773.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call